Literature DB >> 8037401

Adenosine in the termination of albuterol-induced supraventricular tachycardia.

P Cook1, R J Scarfone, R T Cook.   

Abstract

Five percent of children in the United States have asthma. Status asthmaticus is one of the most common conditions for which children seek care in a pediatric emergency department. beta 2-Agonists such as albuterol are the mainstay of emergency therapy for such children. We present a case of a 4-year-old boy who experienced supraventricular tachycardia (SVT) following albuterol therapy. This is believed to be the first report of adenosine being successfully used to treat a child with albuterol-induced SVT. We also briefly review the recognition and management of SVT in children and the pharmacokinetics of and indications for adenosine.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8037401     DOI: 10.1016/s0196-0644(94)70146-6

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  2 in total

1.  Adenosine for salbutamol-induced supraventricular tachycardia.

Authors:  Daniel Trachsel; Christopher J L Newth; Juerg Hammer
Journal:  Intensive Care Med       Date:  2007-05-15       Impact factor: 17.440

2.  Comparison of levalbuterol and racemic albuterol based on cardiac adverse effects in children.

Authors:  Laura L Bio; Vincent J Willey; Cathy Y Poon
Journal:  J Pediatr Pharmacol Ther       Date:  2011-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.